Clinical Trials Logo

Critically Ill clinical trials

View clinical trials related to Critically Ill.

Filter by:

NCT ID: NCT06216080 Recruiting - Critically Ill Clinical Trials

Dynamic Full-Field Optical Coherence Tomography for Structural and Microbiological Characterization of Central Venous Catheter-deposited Biofilm in Critically Ill Patients

OCT-BIO-CVC
Start date: May 1, 2023
Phase:
Study type: Observational

29.3% of bacteremias in intensive care units (ICU) are linked to vascular devices, with a significant proportion related to central venous catheters, and an influence on both morbility and mortality. It is now accepted that microbiological biofilm plays a key role on both bacterial and fungal development on inner surface of vascular devices but there is yet a lack of clinical relevant data documenting a causal relation between biofilm formation and bacteremias. We assume that a more precise characterization of central venous catheter-deposited biofilm could help us better understand invasive medical device-related healthcare infections in critically ill patients.

NCT ID: NCT06158555 Recruiting - Critically Ill Clinical Trials

Targeted Perfusion Based Haemodynamic Management in Critically Ill Patients Using Urethral Perfusion

TARGET UP
Start date: April 1, 2023
Phase: N/A
Study type: Interventional

To assess the safety and feasibility of the IKORUS device in critically ill patients and to gather exploratory data on haemodynamic coherence

NCT ID: NCT06157593 Not yet recruiting - Clinical trials for Mechanical Ventilation

Neurally Adjusted Ventilatory Assist for Weaning From Invasive Mechanical Ventilation in Critically Ill Children

Start date: February 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare weaning from mechanical ventilation in critically ill children. The main questions it aims to answer are: - Will weaning with neurally adjusted ventilatory assist (NAVA) mode ventilation result in shorter ventilator day than synchronised intermittent mandatory ventilation (SIMV) mode? - Will weaning with NAVA mode ventilation result in shorter paediatric intensive care unit (PICU) length of stay than SIMV mode? Participants will be randomised to NAVA or SIMV group for weaning from mechanical ventilation, then PICU outcomes from both groups will be collected, analysed and compared.

NCT ID: NCT06095830 Not yet recruiting - Critically Ill Clinical Trials

Blood Indices of Systemic Inflammation in Critically Ill Patients With Abdominal Sepsis

Start date: November 1, 2023
Phase:
Study type: Observational

This study aims to clarify the role of blood indices of systemic inflammation in ICU-admitted patients with abdominal sepsis to assess their diagnostic significance as well as their prognostic value.

NCT ID: NCT06027008 Recruiting - Critically Ill Clinical Trials

Mechanical Insufflation-Exsufflation (Cough Assist) in Critically Ill Adults

ACACIA
Start date: October 30, 2023
Phase: N/A
Study type: Interventional

The goal of this randomized feasibility trial is to evaluate the feasibility of Mechanical Insufflation-Exsufflation (MI-E) in invasively ventilated critically ill patients. The main question[s] it aims to answer are: - Is MI-E feasible? - Is MI-E safe? Participants in the intervention group will receive: - MI-E - Airway secretions will be removed by endotracheal suctioning, as part of routine airway care. - Manual hyperinflation will only be used when necessary in an emergency situation. Patients in the control group will receive endotracheal suctioning and manual hyperinflation when clinically indicated. The primary outcome is the proportion of delivered MI-E sessions (2 times per calendar day a MI-E session of 3 x 3 cycles of an in- and exsufflation) per patient according to study protocol (feasibility). Secondary outcomes are the total number of serious adverse events in relation to MI-E (safety) and preliminary exploratory data on the need for airway care interventions and clinical outcomes including duration of invasive ventilation, length of stay in ICU and mortality (efficacy).

NCT ID: NCT05961631 Not yet recruiting - Critically Ill Clinical Trials

Bio-electrical Impedance Analysis Derived Parameters for Evaluating Fluid Accumulation

Start date: September 1, 2023
Phase:
Study type: Observational

The purpose of this study is to assess fluid accumulation (FA) in the body using BIA (Bioelectrical Impedance Analysis) in critically ill patients treated in the ICU. This study is an observational cohort with an initial phase that analyzes prospective individual patient data

NCT ID: NCT05953649 Not yet recruiting - Clinical trials for Mechanical Ventilation

Effect of Early Extracorporeal Diaphragm Pacing Combined With Tilt Table in Ventilated Patients.

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

The aim of this study is to test the effect of 1week of extracorporeal diaphragm pacing (EDP) combined either with or without tilt table verticalization (TTV) on diaphragm function in patients with mechanical ventilation compared to conventional physiotherapy (CPT).

NCT ID: NCT05931809 Not yet recruiting - Critically Ill Clinical Trials

Evaluation of the Perception of Quality of Care of Patients Admitted to a Medical-Surgical ICU

Start date: July 1, 2023
Phase:
Study type: Observational

The objective of this prospective observational cohort study is to describe the perception of quality of care of patients or reference companions admitted to a medical-surgical ICU.

NCT ID: NCT05830669 Recruiting - Sepsis Clinical Trials

Remote Ischemic Preconditioning in Septic Patients

RIPC-ICU
Start date: May 11, 2023
Phase: N/A
Study type: Interventional

Acute kidney injury is a well-recognized complication in critically ill patients. Up to date there is no clinically established method to reduce the incidence or the severity of acute kidney injury. Remote ischemic preconditioning (RIPC) will be induced by three cycles of upper limb ischemia. The aim of the study is to reduce the incidence of AKI by implementing remote ischemic preconditioning (identified by the urinary biomarkers tissue inhibitor of metalloproteinases-2 (TIMP-2) and insulin-like growth factor-binding protein 7(IGFBP7)

NCT ID: NCT05810415 Recruiting - Sepsis Clinical Trials

Use of Renin Versus Lactic Acid as Tissue Perfusion Biomarkers for Mortality Prediction in Hypotensive Critically Ill Patients

Start date: June 21, 2022
Phase:
Study type: Observational

Measurement of Whole Blood Lactate Concentrations Whole blood lactate concentrations will be measured at the time of study enrollment and at 24, 48, and 72 hours. Measurement of Plasma Renin Concentrations Serum renin concentration will be measured on blood samples drawn from arterial catheters on supine position right after inclusion. Discarded whole blood samples (waste blood samples) in EDTA tubes are prospectively collected from each patient at the time of study enrollment and at 24, 48, and 72 hours.